Pharmacodynamic biomarker analysis of gastrointestinal cancer patients treated with metronomic chemotherapy in the Italian COMET Trial

被引：0
|
作者：
Manca, Maria L.
Prospero, Diana
Darvishi, Saeedeh
Bandini, Arianna
Banchi, Marta
Orlandi, Paola
Padilla, Hector
Sanchez, Alejandro
Perucho, Claire E.
de Avila, Nydia
Padilla, Hazel
Ortega, Brianna E.
Stewart, Ryley D.
Santillan, Magdiel
Lopez, Valeria
Kirken, Robert
Allegrini, Giacomo
Bocci, Guido
Francia, Giulio
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5180
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients
    Paloma Valenzuela
    Derrick Oaxaca
    Teresa Di Desidero
    Karla Parra
    Georgialina Rodriguez
    Marian Manciu
    Giacomo Allegrini
    Alfredo Falcone
    Guido Bocci
    Robert A. Kirken
    Giulio Francia
    Clinical and Experimental Medicine, 2021, 21 : 149 - 159
  • [2] Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients
    Valenzuela, Paloma
    Oaxaca, Derrick
    Di Desidero, Teresa
    Parra, Karla
    Rodriguez, Georgialina
    Manciu, Marian
    Allegrini, Giacomo
    Falcone, Alfredo
    Bocci, Guido
    Kirken, Robert A.
    Francia, Giulio
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 149 - 159
  • [3] Pharmacodynamic biomarkers in metronomic chemotherapy: Multiplex cytokine measurements in gastrointestinal cancer patients
    Valenzuela, Paloma
    Parra, Karla
    Oaxaca, Derrick
    Reza, Luis
    Lopez, Jose
    Arreguin, Montserrat Garcia
    Garcia, Diana
    Rodriguez, Georgialina
    Falcone, Alfredo
    Allegrini, Giacomo
    Di Desidero, Teresa
    Bocci, Guido
    Kirken, Robert
    Francia, Giulio
    CANCER RESEARCH, 2017, 77
  • [4] Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
    Filippi, Roberto
    Lombardi, Pasquale
    Depetris, Ilaria
    Fenocchio, Elisabetta
    Quara, Virginia
    Chila, Giovanna
    Aglietta, Massimo
    Leone, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (13) : 1451 - 1463
  • [5] Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    Perroud, Herman A.
    Alasino, Carlos M.
    Rico, Maria J.
    Queralt, Francisco
    Pezzotto, Stella M.
    Rozados, Viviana R.
    Scharovsky, O. Graciela
    FUTURE ONCOLOGY, 2016, 12 (10) : 1233 - 1242
  • [6] METRONOMIC CAPECITABINE AS SALVAGE CHEMOTHERAPY IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER (AGIC)
    Barucca, V
    Romiti, A.
    Sarcina, I
    Di Rocco, R.
    Morelli, F.
    Durante, V
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 112 - 112
  • [7] A feasibility trial of antiangiogenic (Metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer
    Kieran, MW
    Turner, CD
    Rubin, JB
    Chi, SX
    Zimmerman, MA
    Chordas, C
    Klement, G
    Laforme, A
    Gordon, A
    Thomas, A
    Neuberg, D
    Browder, T
    Folkman, J
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (11) : 573 - 581
  • [8] What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?
    ElDarsa, Haidar
    El Sayed, Rola
    Abdel-Rahman, Omar
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2297 - 2302
  • [9] A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
    Roberto, Michela
    Romiti, Adriana
    Onesti, Concetta E.
    D'Antonio, Chiara
    Milano, Annalisa
    Falcone, Rosa
    Barucca, Viola
    Palombi, Lucia
    Righini, Riccardo
    Marchetti, Paolo
    ANTI-CANCER DRUGS, 2016, 27 (02) : 106 - 111
  • [10] GASTROINTESTINAL CANCER Rationale for metronomic chemotherapy in phase III trials
    Kerbel, Robert S.
    Grothey, Axel
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (06) : 313 - 314
12345